HEARTSCIENCES INC (HSCS) Stock Price, Quote, News and Overview
NASDAQ:HSCS - Nasdaq - US42254E3027 - Common Stock - Currency: USD
HSCS Quote, Performance and Key Statistics
NASDAQ:HSCS (2/21/2025, 8:26:03 PM)
3.69
-0.12 (-3.17%)
The current stock price of HSCS is 3.69 USD. In the past month the price increased by 6.96%. In the past year, price decreased by -68.94%.
HSCS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About HSCS
Company Profile
HeartSciences Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Southlake, Texas and currently employs 15 full-time employees. The company went IPO on 2022-06-15. HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The firm has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction, which has traditionally only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test. The company delivers AI-ECG algorithms using existing ECG devices across a hospital or health system.
Company Info
HEARTSCIENCES INC
550 Reserve St, Suite 360
Southlake TEXAS US
Employees: 15
Company Website: https://heartsciences.com/
Investor Relations: https://ir.heartsciences.com/
Phone: 16822377781
HEARTSCIENCES INC / HSCS FAQ
What is the stock price of HEARTSCIENCES INC today?
The current stock price of HSCS is 3.69 USD. The price decreased by -3.17% in the last trading session.
What is the ticker symbol for HEARTSCIENCES INC stock?
The exchange symbol of HEARTSCIENCES INC is HSCS and it is listed on the Nasdaq exchange.
On which exchange is HSCS stock listed?
HSCS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for HEARTSCIENCES INC stock?
8 analysts have analysed HSCS and the average price target is 13.77 USD. This implies a price increase of 273.17% is expected in the next year compared to the current price of 3.69. Check the HEARTSCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is HEARTSCIENCES INC worth?
HEARTSCIENCES INC (HSCS) has a market capitalization of 3.62M USD. This makes HSCS a Nano Cap stock.
How many employees does HEARTSCIENCES INC have?
HEARTSCIENCES INC (HSCS) currently has 15 employees.
What are the support and resistance levels for HEARTSCIENCES INC (HSCS) stock?
HEARTSCIENCES INC (HSCS) has a support level at 3.63 and a resistance level at 3.92. Check the full technical report for a detailed analysis of HSCS support and resistance levels.
Is HEARTSCIENCES INC (HSCS) expected to grow?
The Revenue of HEARTSCIENCES INC (HSCS) is expected to decline by -15.68% in the next year. Check the estimates tab for more information on the HSCS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy HEARTSCIENCES INC (HSCS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of HSCS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of HSCS, evaluating the profitability, health, valuation and growth aspects
- HEARTSCIENCES INC (HSCS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- HEARTSCIENCES INC (HSCS) Sales and EPS estimates to see what analysts future expectations are.
- HEARTSCIENCES INC (HSCS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- HEARTSCIENCES INC (HSCS) Insider and Institutional Ownership to learn about the owners and their transactions.
- HEARTSCIENCES INC (HSCS) Stock Chart to make your own analysis
- HEARTSCIENCES INC (HSCS) Latest news and press-releases to stay up to date.
Does HEARTSCIENCES INC (HSCS) stock pay dividends?
HSCS does not pay a dividend.
When does HEARTSCIENCES INC (HSCS) report earnings?
HEARTSCIENCES INC (HSCS) will report earnings on 2025-03-13, after the market close.
What is the Price/Earnings (PE) ratio of HEARTSCIENCES INC (HSCS)?
HEARTSCIENCES INC (HSCS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-26.72).
What is the Short Interest ratio of HEARTSCIENCES INC (HSCS) stock?
The outstanding short interest for HEARTSCIENCES INC (HSCS) is 3.78% of its float. Check the ownership tab for more information on the HSCS short interest.
HSCS Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to HSCS. When comparing the yearly performance of all stocks, HSCS is a bad performer in the overall market: 81.91% of all stocks are doing better.
HSCS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to HSCS. HSCS has a bad profitability rating. Also its financial health evaluation is rather negative.
HSCS Financial Highlights
Over the last trailing twelve months HSCS reported a non-GAAP Earnings per Share(EPS) of -26.72. The EPS increased by 59.52% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -84.93% | ||
| ROE | -164.44% | ||
| Debt/Equity | 0.01 |
HSCS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to HSCS. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 81.01% and a revenue growth -15.68% for HSCS